Conversely, High-Mg tumors displayed high mutation frequencies in well-known initiation driver genes of CRC, such as TP53 and APC, indicating that Mg deficiency may primarily impact tumor progression rather than initiation at the genomic level. The gene discussed is TP53; the disease is neoplasm.